Shareholders to Vote on Change in Use of IPO Proceeds at Next Shanghai Fudan-Zhangjiang Bio-Pharmaceutical EGM

Reuters
2025.10.31 13:31
portai
I'm PortAI, I can summarize articles.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. will hold an extraordinary general meeting to vote on a proposal to change the use of proceeds from its A share IPO. The proposal seeks to reallocate unused funds to a new project, extending the utilization timeline to December 31, 2027. The board recommends voting in favor of this proposal.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. will hold an extraordinary general meeting on a future date to vote on a proposal to change the use of proceeds from its A share initial public offering. The proposal seeks shareholder approval to reallocate unused funds from the original project to a new project, with an adjusted utilisation timeline extending to 31 December 2027. The board recommends voting in favor of the proposal. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. published the original content used to generate this news brief on October 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.